QC
PMVP icon

Quadrature Capital’s PMV Pharmaceuticals PMVP Stock Holding History

Quadrature Capital’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.2K Buy
62,070
+896
+1% +$1.15K ﹤0.01% 1483
2026
Q1 		$75.9K Buy
61,174
+42,746
+232% +$54.4K ﹤0.01% 1256
2025
Q4 		$23K Buy
+18,428
New +$24.7K ﹤0.01% 1205

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Quadrature Capital's PMVP Position: Q2 2026 in Review

Quadrature Capital increased its PMV Pharmaceuticals (PMVP) stake by 1.5% in Q2 2026, buying an estimated $1.15K and bringing the position to 62,070 shares worth $83.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1483.

Quadrature Capital first reported a position in PMVP in Q4 2025 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Quadrature Capital held 62,070 shares of PMV Pharmaceuticals worth $83.2K as of Q2 2026.
  • Quadrature Capital bought 896 PMV Pharmaceuticals shares in Q2 2026, an estimated $1.15K.
  • PMV Pharmaceuticals made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1483 holding.
  • Quadrature Capital first reported a position in PMV Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.